Press Releases
SOMAÍ Pharmaceuticals launches in Ireland, offering the widest range of cannabis-based medicines to patients

SOMAÍ Pharmaceuticals partners with Georgelle Pharmaceutical to introduce wide range of cannabis-based medicines to Ireland
LISBON, PORTUGAL, September 17, 2024 /EINPresswire.com/ — SOMAÍ Pharmaceuticals (“SOMAÍ”), a leading EU GMP vertically integrated Multinational Operator (MCO) company with a global distribution footprint of the largest and most advanced EU GMP certified portfolio of cannabinoid-containing pharmaceutical extracts, is proud to announce its partnership with Georgelle Pharmaceutical Ltd (“Georgelle”), to bring an innovative range of cannabis-based medicines to patients in Ireland.
This partnership represents a significant milestone for SOMAÍ Pharmaceuticals as it extends its global footprint to Ireland, making it the fifth country to establish a presence, following successful expansions into the UK, Australia, Germany and Poland earlier this year.
Under the terms of the three-year agreement, SOMAÍ will provide a consistent, varied and differentiated portfolio of cannabinoid-containing products to all clinics and doctors prescribing cannabis in Ireland, using Georgelle’s distribution network. Irish patients will initially have access to a range of single-strain THC, CBD and balanced oral solutions.
The product line will later be expanded to include mint-infused oral solutions with different terpene lines, and inhalation extracts with increased terpene levels, all part of SOMAÍ’s Origins and Senses line.
The company is committed to ensuring that Irish patients can access a wide range of cannabis-based medicines with enhanced flavour and tailored terpene blends, effectively addressing their specific needs.
“SOMAÍ is proud to enter Ireland with a great partner in Georgelle. Offering Irish patients a full range of products and options will further expand the demographic that needs medicinal cannabis and has suffered from limited treatment options. Irish patients deserve access, through Georgelle, to SOMAÍ’s dedicated portfolio of cannabis extracts and a wide range of non-irradiated indoor flower lines,” said Michael Sassano, Founder and Interim CEO of SOMAÍ Pharmaceuticals.
“We are excited and proud to partner with SOMAÍ Pharmaceuticals. We have followed the great strides SOMAÍ has made to date and recognized the great potential in the collaboration given our similar attitudes toward patient care. We admire their commitment to innovation and making a positive impact and their dedication to providing a broad range of medicines to meet the diverse needs of patients,” said Daniel O’Brien, CSO of Georgelle Ltd.
About SOMAÍ Pharmaceuticals
SOMAÍ Pharmaceuticals is a leading EU GMP vertically integrated Multinational Operator (MCO) company with a global distribution presence of the largest and most advanced portfolio of EU GMP certified cannabinoid-containing pharmaceutical extracts.
At SOMAÍ, we are building a leading global brand with the most robust pipeline of innovative cannabis-based therapeutics. We envision a world where people live a healthy lifestyle powered by natural cannabis medicine.
SOMAÍ has state-of-the-art indoor cultivation and production facilities in Lisbon, Portugal, and has global sales teams in the largest medical cannabis markets. We continue to make global brand acquisitions and partnerships that make us one of the few and first vertically integrated European companies in the EU, able to meet the diverse needs of the rapidly growing global cannabis markets.
About Georgelle Pharmacist
A family-owned business, Georgelle has been a leading pharmaceutical wholesaler in Ireland for over 40 years. Georgelle works closely with leading cannabis-based medicines manufacturers to expand its reach in Ireland and provide patients and physicians with a seamless delivery of medicines across the country.
____________________________________________________________________________________________________
[Disclaimer: Please note that this text was originally written in Portuguese and is translated into English and other languages using an automatic translator. Some words may differ from the original and typos or errors may occur in other languages.]____________________________________________________________________________________________________
What do you do with €3 a month? Become one of our Patrons! If you believe that independent cannabis journalism is necessary, subscribe to one of the levels of our Patreon account and you will have access to unique gifts and exclusive content. If there are many of us, we can make a difference with little!

CannaReporter
